Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial
| Image |  |
|---|---|
| Description | scientific article published on 28 March 2019 |
| Author/s |
author: Loretta J Nastoupil Michael Wang Melody R Becnel Felipe Samaniego Nathan H Fowler Luis E. Fayad Michelle A Fanale Jason R Westin Sattva S Neelapu Yasuhiro Oki Fredrick B Hagemeister Sheryl G Forbes Michael Green |
| Publication date | March 28, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |